127 related articles for article (PubMed ID: 8944840)
21. Expression of the retinoblastoma gene product in renal tumors.
Presti JC; Reuter VE; Cordon-Cardo C; Motzer RJ; Albino AP; Jhanwar SC; Nanus DM
Anticancer Res; 1996; 16(2):549-56. PubMed ID: 8687097
[TBL] [Abstract][Full Text] [Related]
22. Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: correlation with clinicopathological features.
Kaur J; Das SN; Srivastava A; Ralhan R
Oral Oncol; 1998 Mar; 34(2):93-8. PubMed ID: 9682770
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
24. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
25. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
[TBL] [Abstract][Full Text] [Related]
26. pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma.
Tanaka N; Ogi K; Odajima T; Dehari H; Yamada S; Sonoda T; Kohama G
Cancer; 2001 Oct; 92(8):2117-25. PubMed ID: 11596028
[TBL] [Abstract][Full Text] [Related]
27. p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.
Busatto G; Shiao YH; Parenti AR; Baffa R; Ruol A; Plebani M; Rugge M
Mol Pathol; 1998 Apr; 51(2):80-4. PubMed ID: 9713590
[TBL] [Abstract][Full Text] [Related]
28. Retinoblastoma (Rb) protein expression and resistance in squamous cell lung carcinomas.
Volm M; Stammler G
Anticancer Res; 1996; 16(2):891-4. PubMed ID: 8687146
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.
Jordan RC; Catzavelos GC; Barrett AW; Speight PM
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):394-400. PubMed ID: 9039223
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
J Surg Oncol; 2000 Feb; 73(2):104-8. PubMed ID: 10694647
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.
Chetty R; Chetty S
Mol Pathol; 1997 Oct; 50(5):257-60. PubMed ID: 9497916
[TBL] [Abstract][Full Text] [Related]
33. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
[TBL] [Abstract][Full Text] [Related]
34. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications.
El-Naggar AK; Lai S; Clayman GL; Zhou JH; Tucker SA; Myers J; Luna MA; Benedict WF
Hum Pathol; 1999 Sep; 30(9):1013-8. PubMed ID: 10492034
[TBL] [Abstract][Full Text] [Related]
35. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
36. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
37. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
Koo BS; Lim YC; Lee JS; Choi EC
Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
[TBL] [Abstract][Full Text] [Related]
38. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
[TBL] [Abstract][Full Text] [Related]
39. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
[TBL] [Abstract][Full Text] [Related]
40. Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma.
Albuquerque RL; Miguel MC; Costa AL; Souza LB
Int J Exp Pathol; 2003 Dec; 84(6):259-65. PubMed ID: 14748745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
